SCHEMBL8072339

SCHEMBL8072339

COc1ccc(CN2C3C=CC(C3)C2c2cccnc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 1/20 0.44
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
TDP1 Q9NUW8 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
CYP3A4 P08684 1/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
PKM P14618 1/20 0.39
RAB9A P51151 1/20 0.39
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
TP53 P04637 1/20 0.38
MDM2 Q00987 1/20 0.38
PTAFR P25105 2/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8075941 0.86 TP53 (0.51) ALDH1A1KDM4ETP53MDM2MAPT
SCHEMBL8072336 0.81 ALDH1A1 (0.43) ALDH1A1KDM4ETDP1CNR1CNR2
SCHEMBL9058332 0.80 CYP2A6 (0.40) ALDH1A1KDM4ECYP3A4KMT2AMEN1
SCHEMBL8077458 0.80 CYP2A6 (0.40) ALDH1A1KDM4ECYP3A4KMT2AMEN1
SCHEMBL8070733 0.73 CHRNB2 (0.46) ALDH1A1TDP1MAPT
SCHEMBL19463213 0.69 HCRTR1 (0.53) DRD4ALDH1A1KDM4ETDP1HDAC1
SCHEMBL20897358 0.69 HCRTR1 (0.53) DRD4ALDH1A1KDM4ETDP1HDAC1
SCHEMBL19463214 0.69 HCRTR1 (0.53) DRD4ALDH1A1KDM4ETDP1HDAC1
SCHEMBL24154837 0.67 KDM4E (0.42) ALDH1A1KDM4ETDP1CYP3A4KMT2A
SCHEMBL24154365 0.66 LMNA (0.47) DRD4ALDH1A1KDM4ETDP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6100269-A ADMINISTERING TO PATIENT NICOTINIC RECEPTOR AGONISTIC DERIVATIVES OF 3-(PYRIDYL OR PYRIMIDYL)-2-AZABICYCLO(2.2.1) HEPTANE OR 2-AZABICYCLO(2.2.2.)OCTANE TO ELICIT NEUROTRANSMITTER SECRETION WITH REDUCED SIDE EFFECTS BENCHERIF MEROUANE (US) 2000-08-08 US disclosed
US-5583140-A ADMINISTERING 2-AZABICYCLO(2.2.2)OCT-5-ENE DERIVATIVES TO TREAT NEURODEGENERATIVE DISORDERS SUCH AS SENILE DEMENTIA OF ALZHEIMER'S TYPE TARGACEPT, INC. A CORP. OF DE, 1996-12-10 US disclosed
WO-1996036637-A1 PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS R.J. REYNOLDS TOBACCO COMPANY (US) 1996-11-21 WO disclosed
WO-1996036637-A1 PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS R.J. REYNOLDS TOBACCO COMPANY (US) 1996-11-21 WO disclosed